Nanomedicine Approaches for Treating Glioblastoma
Authors:
- 18 August 2023
- journal article
- editorial
- Published by Taylor & Francis in Nanomedicine
- Vol. 18 (18) , 1135-1138
Abstract
No abstract availableKeywords
Funding Information
- Fundação para a Ciência e a Tecnologia (SFRH/BD/06611/2020 and SFRH/BD/06709/2021)
- Horizon 2020 Framework Programme (951723)
- NORTE2020 (Norte-01-0145-FEDER-000051)
This publication has 18 references indexed in Scilit:
- Therapeutically Significant MicroRNAs in Primary and Metastatic Brain MalignanciesCancers, 2020
- Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticlesJournal of Controlled Release, 2019
- Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resectionJournal of Controlled Release, 2019
- Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiformeNature Communications, 2017
- Breakable Hybrid Organosilica Nanocapsules for Protein DeliveryAngewandte Chemie International Edition, 2015
- EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network RemodelingMolecular Cell, 2015
- Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomasBiomaterials, 2014
- Bevacizumab in Glioblastoma — Still Much to LearnNew England Journal of Medicine, 2014
- Expression of Interleukin-13 Receptor α2 in Glioblastoma Multiforme: Implications for Targeted TherapiesCancer Research, 2007
- The blood-brain barrier: Bottleneck in brain drug developmentNeuroRX, 2005